Expanding Market Potential With a focus on neuro-ophthalmology and ophthalmology, the company’s breakthrough therapies like Privosegtor address a substantial unmet medical need with an unaddressed market potential of 7 billion USD in the US, presenting significant sales opportunities in clinical and pharmaceutical sectors.

Strong Regulatory Progress The recent FDA breakthrough therapy designation for Privosegtor highlights a clear pathway towards accelerated approval, increasing the likelihood of early market entry and opening doors for strategic partnerships with healthcare providers and regulators.

Innovative Technology Platform Developing small molecule neuroprotective candidates capable of crossing blood-brain and retinal barriers positions the company as a leader in cutting-edge biologics, which can attract collaborations from biotech firms seeking advanced ophthalmology and neuro-therapies.

Diversified Revenue Streams Operating within a niche but growing high-tech semiconductor industry serving aerospace, defense, and commercial imaging markets, the company’s infrared detectors are integral to numerous top brands, helping to expand sales across multiple sectors including defense contracts and commercial imaging.

Strategic Market Positioning As Europe’s leading IR detector manufacturer for space applications and with ongoing advancements in infrared technology, the company is well-positioned to capitalize on emerging defense and space market demands, offering potential for new tech sales and strategic industry collaborations.